Table 2 The distribution of APOE genotyping in all studied cases
APOE genotyping & alleles | Control group. N = 100 | Obese cases N = 100 | obese cases with T2DM N = 100 | P- value | ||
|---|---|---|---|---|---|---|
Control Vs obese cases | Control Vs obese cases withT2DM | Obese cases without and with T2DM | ||||
E3/E3 (ref) | 19 (19%) | 21 (21%) | 13 (13%) | 0.055 | < 0.001 | 0.005 |
E2/E2 | 0 | 3 (3%) | 7 (7%) | |||
E2/E3 | 15 (15%) | 26 (26%) | 10 (10%) | |||
E2/E4 | 20 (20%) | 11 (11%) | 22 (22%) | |||
E3/E4 | 46 (46%) | 39 (39%) | 31 (31%) | |||
E4/E4 | 0 | 0 | 17 (17%) | |||
E3 (ref) | 99 (45.5%) | 79 (39.5%) | 67 (33.5%) | < 0.001 | 0.005 | < 0.001 |
E2 | 35 (17.5%) | 71 (35.5%) | 46 (23%) | |||
E4 | 66 (33%) | 50 (25%) | 87 (43.5%) | |||